INOVIO PHARMACEUTICALS, INC. Equity Securities, FV-NI
INOVIO PHARMACEUTICALS, INC. (INO) had Equity Securities, FV-NI of $2.10 million as of 2025-12-31, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:EquitySecuritiesFvNi · last filed 2026-08-12
- 2025-12-31: Equity Securities, FV-NI $2.10M.
- 2024-12-31: Equity Securities, FV-NI $1.61M.
- 2021-03-31: Equity Securities, FV-NI $3.63M.
- 2020-12-31: Equity Securities, FV-NI $4.46M.
| Period end | Equity Securities, FV-NI | Equity Securities, FV-NI as first filed |
|---|---|---|
| 2025-12-31 | $2.10M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $1.61M 10-K · filed 2026-03-12 | |
| 2021-03-31 | $3.63M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $4.46M 10-Q · filed 2021-05-10 | |
| 2020-09-30 | $4.15M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $17.33M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $21.21M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $6.32M 10-K · filed 2021-03-01 | |
| 2019-06-30 | $2.16M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $2.23M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $9.41M 10-K · filed 2020-03-12 | $3.02M 10-K · filed 2019-03-12 |
| 2018-09-30 | $3.20M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $2.67M 10-Q · filed 2018-08-07 | |
| 2017-12-31 | $2.33M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |